Biotech Values

[dumaflotchie]

Dew, do you know what the terms for the MNTA agreement were back so many years ago. Was it "exclusive" rights and indefinite in timeframe?

It still seems to me that MNTA should be negotiating with NVS regarding mitigating the royalty arrangement back in favor of a profit sharing arrangement.

At some point in time, when MNTA gets its FoB program going, it may just hold as grudge for NVS being a pig on lovenox (? capoxone) when no such position was necessary.

Were it me, I would be first knocking on NVS's door......right here, right now.

Take that "royalty" overhang off this company and its stock can ride with the wind.